TVTX logo

Travere Therapeutics (TVTX) CAPEX

annual CAPEX:

$101.21M+$59.62M(+143.35%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TVTX annual capital expenditures is $101.21 million, with the most recent change of +$59.62 million (+143.35%) on December 31, 2024.
  • During the last 3 years, TVTX annual CAPEX has risen by +$77.06 million (+319.08%).
  • TVTX annual CAPEX is now -15.55% below its all-time high of $119.84 million, reached on December 31, 2020.

Performance

TVTX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

quarterly CAPEX:

$11.78M+$2.22M(+23.25%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX quarterly capital expenditures is $11.78 million, with the most recent change of +$2.22 million (+23.25%) on March 31, 2025.
  • Over the past year, TVTX quarterly CAPEX has increased by +$5.32 million (+82.25%).
  • TVTX quarterly CAPEX is now -88.66% below its all-time high of $103.88 million, reached on December 31, 2020.

Performance

TVTX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TTM CAPEX:

$106.53M+$5.32M(+5.25%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TVTX TTM capital expenditures is $106.53 million, with the most recent change of +$5.32 million (+5.25%) on March 31, 2025.
  • Over the past year, TVTX TTM CAPEX has increased by +$86.44 million (+430.26%).
  • TVTX TTM CAPEX is now -14.43% below its all-time high of $124.50 million, reached on March 31, 2021.

Performance

TVTX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TVTX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+143.3%+82.3%+430.3%
3 y3 years+319.1%+123.7%+428.7%
5 y5 years+550.3%+155.4%+517.7%

TVTX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+319.1%-84.7%+207.2%at high+430.3%
5 y5-year-15.6%+550.3%-88.7%+207.2%-14.4%+517.7%
alltimeall time-15.6%+2453.3%-88.7%>+9999.0%-14.4%>+9999.0%

TVTX CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$11.78M(+23.3%)
$106.53M(+5.3%)
Dec 2024
$101.21M(+143.4%)
$9.56M(+16.7%)
$101.21M(+4.9%)
Sep 2024
-
$8.19M(-89.4%)
$96.51M(+3.5%)
Jun 2024
-
$76.99M(+1090.7%)
$93.25M(+364.1%)
Mar 2024
-
$6.47M(+33.0%)
$20.09M(-51.7%)
Dec 2023
$41.59M(+46.6%)
$4.86M(-1.3%)
$41.59M(+2.1%)
Sep 2023
-
$4.93M(+28.4%)
$40.73M(-6.5%)
Jun 2023
-
$3.84M(-86.3%)
$43.59M(-14.6%)
Mar 2023
-
$27.97M(+598.1%)
$51.07M(+80.0%)
Dec 2022
$28.37M(+17.5%)
$4.01M(-48.5%)
$28.37M(-4.0%)
Sep 2022
-
$7.78M(-31.2%)
$29.56M(+8.9%)
Jun 2022
-
$11.31M(+114.8%)
$27.15M(+34.8%)
Mar 2022
-
$5.27M(+1.3%)
$20.15M(-16.6%)
Dec 2021
$24.15M(-79.8%)
$5.20M(-3.2%)
$24.15M(-80.3%)
Sep 2021
-
$5.37M(+24.8%)
$122.83M(-1.2%)
Jun 2021
-
$4.31M(-53.5%)
$124.37M(-0.1%)
Mar 2021
-
$9.27M(-91.1%)
$124.50M(+3.9%)
Dec 2020
$119.84M(+670.0%)
$103.88M(+1402.2%)
$119.84M(+500.9%)
Sep 2020
-
$6.92M(+55.9%)
$19.95M(+15.6%)
Jun 2020
-
$4.44M(-3.9%)
$17.25M(+6.5%)
Mar 2020
-
$4.61M(+15.9%)
$16.20M(+4.1%)
Dec 2019
$15.56M
$3.98M(-5.6%)
$15.56M(+0.7%)
DateAnnualQuarterlyTTM
Sep 2019
-
$4.22M(+24.5%)
$15.45M(+2.5%)
Jun 2019
-
$3.39M(-14.9%)
$15.08M(-2.2%)
Mar 2019
-
$3.98M(+2.9%)
$15.43M(-21.7%)
Dec 2018
$19.70M(+40.6%)
$3.87M(+0.5%)
$19.70M(+4.9%)
Sep 2018
-
$3.85M(+3.0%)
$18.77M(+0.6%)
Jun 2018
-
$3.73M(-54.8%)
$18.66M(+4.0%)
Mar 2018
-
$8.26M(+180.8%)
$17.95M(+28.1%)
Dec 2017
$14.01M(+17.5%)
$2.94M(-21.3%)
$14.01M(-8.4%)
Sep 2017
-
$3.73M(+23.7%)
$15.30M(+6.6%)
Jun 2017
-
$3.02M(-30.0%)
$14.35M(+5.2%)
Mar 2017
-
$4.32M(+2.0%)
$13.64M(+14.4%)
Dec 2016
$11.92M(+69.6%)
$4.23M(+51.8%)
$11.92M(+26.6%)
Sep 2016
-
$2.79M(+20.9%)
$9.42M(+0.1%)
Jun 2016
-
$2.31M(-11.3%)
$9.41M(+8.7%)
Mar 2016
-
$2.60M(+50.8%)
$8.66M(+23.1%)
Dec 2015
$7.03M(+77.3%)
$1.72M(-38.0%)
$7.03M(+30.5%)
Sep 2015
-
$2.78M(+79.0%)
$5.39M(+94.8%)
Jun 2015
-
$1.55M(+59.6%)
$2.77M(-41.3%)
Mar 2015
-
$973.00K(+1101.2%)
$4.71M(+18.8%)
Dec 2014
$3.96M
$81.00K(-48.7%)
$3.96M(+2.1%)
Sep 2014
-
$158.00K(-95.5%)
$3.88M(+4.2%)
Jun 2014
-
$3.50M(+1437.4%)
$3.73M(+1537.4%)
Mar 2014
-
$227.50K
$227.50K

FAQ

  • What is Travere Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Travere Therapeutics?
  • What is Travere Therapeutics annual CAPEX year-on-year change?
  • What is Travere Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Travere Therapeutics?
  • What is Travere Therapeutics quarterly CAPEX year-on-year change?
  • What is Travere Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Travere Therapeutics?
  • What is Travere Therapeutics TTM CAPEX year-on-year change?

What is Travere Therapeutics annual capital expenditures?

The current annual CAPEX of TVTX is $101.21M

What is the all time high annual CAPEX for Travere Therapeutics?

Travere Therapeutics all-time high annual capital expenditures is $119.84M

What is Travere Therapeutics annual CAPEX year-on-year change?

Over the past year, TVTX annual capital expenditures has changed by +$59.62M (+143.35%)

What is Travere Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of TVTX is $11.78M

What is the all time high quarterly CAPEX for Travere Therapeutics?

Travere Therapeutics all-time high quarterly capital expenditures is $103.88M

What is Travere Therapeutics quarterly CAPEX year-on-year change?

Over the past year, TVTX quarterly capital expenditures has changed by +$5.32M (+82.25%)

What is Travere Therapeutics TTM capital expenditures?

The current TTM CAPEX of TVTX is $106.53M

What is the all time high TTM CAPEX for Travere Therapeutics?

Travere Therapeutics all-time high TTM capital expenditures is $124.50M

What is Travere Therapeutics TTM CAPEX year-on-year change?

Over the past year, TVTX TTM capital expenditures has changed by +$86.44M (+430.26%)
On this page